Menu

Blog

Nov 29, 2022

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Posted by in category: neuroscience

The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health or Care Research, or the Department of Health and Social Care in the United Kingdom.

This article was updated on November 3, 2022, at NEJM.org.

A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.

Comments are closed.